DPLO Average Annual Return Since 2014
Growth of $10,000.00
Without Dividends Reinvested Into DPLO


Also see:
DPLO stock yearly return 2015
DPLO stock yearly return 2016
DPLO stock yearly return 2017
DPLO stock yearly return 2018
DPLO stock yearly return 2019
DPLO stock yearly return 2020
DPLO YTD return
Compare DPLO average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Start date: 10/10/2014
End date: 02/07/2020
Start price/share: $16.02
End price/share: $4.00
Dividends collected/share: $0.00
Total return: -75.03%
Average Annual Total Return: -22.91%
Starting investment: $10,000.00
Ending investment: $2,497.64
Years: 5.33


DPLO average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
Diplomat Pharmacy is a provider of specialty pharmacy services. Co.'s programs consist of the following business services: Dispensing of Specialty Pharmacy and Infusion Drugs, which is engages in the dispensing of drugs and the reporting of data associated with those dispenses to pharmaceutical manufacturers and other outside companies; Hospital and Health System Services, which provides clinical and administrative support services to hospitals and health systems that dispense medications through their outpatient pharmacies; and Hub Services, which are centralized management services for collaboration and efficiency among the main stakeholders in the access of care to medications. The DPLO average annual return since 2014 is shown above.

The Average Annual Return on the DPLO average annual return since 2014 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether DPLO average annual return since 2014 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the DPLO average annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes
Get Free SEC filing alerts for DPLO:
DPLO SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
DPLO (DPLO) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

DRAD Average Annual Return
DRIO Average Annual Return
DRNA Average Annual Return
DRRX Average Annual Return
DVA Average Annual Return
DVAX Average Annual Return
DVCR Average Annual Return
DXCM Average Annual Return
DYNT Average Annual Return
EBS Average Annual Return
More Healthcare companies »

 

DPLO Average Annual Return Since 2014 | www.AverageAnnualReturn.com | Copyright © 2021 - 2021, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.